Chromium Picolinate Supplementation Research Articles

Dietary Supplementation of Chromium Picolinate does not affect Growth Performance and Feed Conversion Ratio of Rainbow Trout (Oncorhynchus mykiss)

Aims: A growth experiment was conducted to explore the impact of dietary chromium on the growth performance and feed conversion ratio of rainbow trout (Oncorhynchus mykiss).
 Study Design: Original Research Article
 Place and Duration of Study: Fisheries Research Station (FRS), Trishuli Nepal, between November 1 to January 29, 2023.
 Methodology: A total of 270 healthy and equal sized- O. mykiss (initial weight: 27g) were fed on a non-supplemented basal diet (Cr-Pic0), or a basal diet supplemented with 0.4g/kg Cr-Pic (Cr-Pic0.4), or a basal diet supplemented with 1.2g/kg Cr-Pic (Cr-Pic1.2) for 90 days. Each diet was randomly assigned to three replicate groups of 30 fish per flowthrough raceway tanks for 90 days and fed to apparent satiation twice daily.
 Results: Upon conclusion of the feeding trial, the results showed no significant differences in final weight, weight gain, specific growth rate, or condition factor among treatments (P>0.05). There were also no significant differences in the survival rate and feed conversion ratio of the rainbow trout fed various experimental diets (P>0.05).
 Conclusion: The results suggest that growth performance, food conversion, and survival of rainbow trout fingerlings are not affected by 0.4 or 1.2 mg/kg supplementation of Cr-Pic in diet.

Chromium Picolinate Protects against Testicular Damage in STZ-Induced Diabetic Rats via Anti-Inflammation, Anti-Oxidation, Inhibiting Apoptosis, and Regulating the TGF-β1/Smad Pathway.

Chromium picolinate (CP) is an organic compound that has long been used to treat diabetes. Our previous studies found CP could relieve diabetic nephropathy. Thus, we speculate that it might have a positive effect on diabetic testicular injury. In this study, a diabetic rat model was established, and then the rats were treated with CP for 8 weeks. We found that the levels of blood glucose, food, and water intake were reduced, and body weight was enhanced in diabetic rats after CP supplementation. Meanwhile, in CP treatment groups, the levels of male hormone and sperm parameters were improved, the pathological structure of the testicular tissue was repaired, and testicular fibrosis was inhibited. In addition, CP reduced the levels of serum inflammatory cytokines, and decreased oxidative stress and apoptosis in the testicular tissue. In conclusion, CP could ameliorate testicular damage in diabetic rats, as well as being a potential testicle-protective nutrient in the future to prevent the testicular damage caused by diabetes.

Effect of chromium(III) glycinate and picolinate supplementation on antioxidant status and calcium, magnesium and phosphorus levels in diabetic rats

Effect of chromium(III) glycinate and picolinate supplementation on antioxidant status and calcium, magnesium and phosphorus levels in diabetic rats

Dietary Chromium Picolinate Supplementation Improves Glucose Utilization in Transition Calf by Ameliorating Insulin Response.

The decrease in insulin sensitivity during the transition of preruminant calves into ruminant animals is the common denominator. Meanwhile, this adaptation predisposes dairy calves towards various health issues and metabolic disorders that occur in later life. Chromium (Cr) has been shown to potentiate insulin functioning and is thereby helpful in reducing the risk of these metabolic disorders. The aim of this study was to assess the effect of Cr supplementation on the insulin sensitivity and health status in Hariana calves during their transition period. A total of 24 preruminant Hariana calves were randomly allocated into four groups (6 calves per group) for a period of 90days. Calves either received a basal diet devoid of supplemental Cr (control; Cr0.0 group) or were supplemented with 0.05mg (Cr0.05 group), 0.10mg (Cr0.10 group), and 0.15mg (Cr0.15 group) of Cr per kg BW0.75 as Cr-picolinate (Cr-Pic). To determine the effect of Cr supplementation on the insulin response, glucose-insulin-non-esterified fatty acids (NEFAs) kinetics was studied during the intravenous glucose tolerance test (IVGTT) and oral glucose tolerance test (OGTT). A rapid glucose disappearance (p < 0.05) with unaltered insulin kinetics during IVGTT and OLTT indicates greater insulin sensitivity in calves supplemented with 0.10 and 0.15mg of Cr per kg BW0.75. Improved insulin sensitivity in the Cr0.10 and Cr0.15 groups was further confirmed by higher (p < 0.05) values of the insulin sensitivity check index (QUICKI), revised quantitative insulin sensitivity check index (RQUICKI), and lower (p < 0.05) values of the homeostasis model assessment-insulin resistance (HOMA-IR) during IVGTT. Mean serum non-esterified fatty acids (NEFAm), and insulin receptor substrate-1 (IRS-1) levels were the highest (p < 0.05) and cortisol concentrations were the lowest (p < 0.05) in the Cr0.15 groups. Unlike IVGTT, there was no effect of treatment, period, and treatment × period interaction on mean serum glucose and insulin levels during OGTT. However, Cr-supplemented calves had a higher (p < 0.05) glucose clearance rate (gCR). Serum IRS-1 concentrations during OGTT were also higher (p < 0.05) in the Cr0.10 and Cr0.15 groups than in the other groups. Serum Cr levels increased dose dependently and were the highest (p < 0.05) in calves fed a diet supplemented with 0.15mg Cr per kg BW0.75. There was no effect of treatment on average daily gain (ADG) and body condition score (BCS) while frequency and duration of diarrhea were lower and fecal score was better in Cr-supplemented calves. The current findings show that Cr supplementation improved glucose utilization and health status in calves during their transition period by improving insulin sensitivity.

Chromium picolinate supplementation improves cardiac performance in hypoxic rats

Background Conditions associated with chronic hypoxia increase morbidity and mortality attributable to cardiovascular complications. Myocardial hypoxia is a common feature in several diseases including: stroke, infarction, anaemia, chronic lung diseases, obstructive sleep apnoea and cyanotic congenital heart defects. The present study was planned to investigate the cardiovascular effects of chronic intermittent hypoxia and its association with increased myocardial oxidative stress. In addition, to evaluate the protective effect of chromium supplementation, aiming at achieving an alternative that may enable to devise a therapy for hypoxic patients. Methods Male rats were allocated into three groups: control group (normoxic), untreated hypoxic group (exposed to hypoxia 8 h/day, 5 days/week for 6 weeks) and hypoxic group supplemented with chromium picolinate (90 µg/kg/day by gavage). Rats were subjected to measurement of body weight, haematocrit value, mean arterial blood pressure, heart rate and ECG recording. Cardiac activities of isolated hearts were studied on Langendorff preparation under basal conditions and in response to ischaemia/reperfusion. Thereafter, cardiac weights were determined and cardiac tissue catalase activity as well as malondialdhyde level were assessed. Results Significant results were obtained upon exposure to hypoxia including; low body weight, increased haematocrit, elevated blood pressure, left ventricular hypertrophy and impaired cardiac activities, basally and in response to ischaemia/reperfusion challenges, associated with increased oxidative stress in cardiac tissue. At the same time, chromium supplementation increased body weight, lowered blood pressure, reduced ventricular hypertrophy and significantly improved the cardiac performance. Conclusion Chromium supplementation confers protection against hypoxia-induced cardiovascular dysfunction by improvement of the antioxidant capacity.

Implementation of Transtheoretical Model Nutrition Education and Chromium Picolinate Supplementation on Improved Dietary Adherence Behavior, Chromium Consumption Pattern and Blood Glucose Level Diabetes Mellitus Patients

Bali is one of the provinces in Indonesia that has a Diabetes Mellitus rate above the national prevalence. According to the results of the 2020 study, 56.9% of DM patients did not understand diet education and did not comply with the diet by 56.9% with abnormal blood glucose levels of 63.9%. The results confirmed that repeated exposure with the right method, especially with The theoretical model is very effective in increasing knowledge and adherence to diet and chromium consumption patterns in DM patients. Chromium is effective in improving blood glucose levels in people with Diabetes Mellitus (Types 1 and 2). Chromium improves glucose metabolism in patients with prediabetic glucose intolerance and all women with gestational diabetes. The purpose of this study was to determine the role of nutrition education using a transtheoretical model and the effect of chromium picolinate supplementation on dietary adherence behavior, chromium consumption patterns, and blood glucose levels in patients with diabetes mellitus. This type of research is quasi-experimental. The research design used was one group pretest-posttest. This design does not use a comparison group (control) but uses the first observation (pretest) which allows testing the changes that occur after the experiment or program (Notoatmodjo, 2010). The study was conducted at the Denpasar Health Center. The results showed that there were differences in the level of knowledge and consumption of chromium and blood glucose levels in DM patients. However, there was no difference in the attitude and level of dietary compliance of DM patients.

An investigation on dietary chromium picolinate supplementation in the juvenile sea cucumber Apostichopus japonicus: Growth, digestive enzyme activity, growth-related genes expression, immune and antioxidant capacity

Improving the growth and immune responses are important to enhance the production efficiency of cultured juvenile sea cucumber Apostichopus japonicus. Here, 300 sea cucumbers (2.31 ± 0.01 g) were fed artificial diets with four concentrations of dietary chromium picolinate (Cr-Pic) supplementation (0, 0.3, 0.6 and 0.9 mg/kg) for 56 days. The growth performance, digestive enzyme activity (lipase, amylase and pepsin), expressions of growth-related genes (MAPK-7 and c-myc), and immune and antioxidant capacity were subsequently assessed. The present study found that final body weight, body weight gain and specific growth rate first increased and then declined with the increase of dietary Cr-Pic supplementation, while the highest values were observed in group 0.6 mg/kg. Consistently, significantly greater feed intake and significantly lower feed conversion ratio occurred in group 0.6 mg/kg than those in control group. Significantly better activities of lipase and amylase, and significantly higher expressions of genes MAPK-7 and c-myc were detected in group 0.6 mg/kg than those in control group. These results suggest that dietary Cr-Pic supplementation greatly improves the food utilization and expressions of growth-related genes, which consequently promotes the growth of sea cucumbers. Further, the activities of immune enzymes (alkaline phosphatase and lysozyme) and antioxidant enzymes (superoxide dismutase and total antioxidant capacity) in group 0.6 mg/kg were all significantly higher than those in control group. This indicates that dietary Cr-Pic supplementation significantly facilitates the immune and antioxidant capacity of sea cucumbers. In conclusion, we suggest dietary Cr-Pic supplementation with 0.6 mg/kg is the optimal level contributing to the growth and non-specific immune responses in the juvenile sea cucumber.

Alleviation of cold stress induced oxidative stress in White Leghorn Chicken by Chromium and Vitamin C supplementation

White Leghorn layer chicken experienced cold stress during December, 2019 to January, 2020 with lowestminimum AT and lowest average temperature during later part of January, 2020. Cold stress caused increasein HSP70 and SOD of White Leghorn layer chicken. Supplementation of chromium picolinate (@ 400 μg/kgfeed) and vitamin C (@ 250 mg/kg of feed) alleviated cold stress and cold induced oxidative stress in White Leghornchicken. Alleviation of stress by supplementation of chromium picolinate and vitamin C could be estimated bythe measure of drop in HSP70 and SOD. Supplementation of chromium picolinate and vitamin C also had beneficialimpacts on egg length during cold stress. Combination of chromium picolinate and vitamin C was best to alleviatecold stress while vitamin C was best to lower oxidative stress in layer.

Lipid profile of subcutaneous fat, growth performance, and carcass characteristics of gilts fed with diets supplemented with ractopamine, organic chromium or subjected to energetic feed restriction

ABSTRACT: This study identified the effects of dietary supplementation with ractopamine, chromium picolinate, chromium yeast, or an energetic feed restriction on the growth performance and lipid profile of subcutaneous fat, in late finishing gilts. Twenty genetically similar gilts with initial body weight of 105.35 ± 4.77 kg and a final body weight of 131.37 ± 5.58 kg were distributed in a completely randomized block design with five treatments (control; ractopamine: 20 ppm; chromium picolinate: 0.48 ppm; chromium yeast: 0.80 ppm; and energetic feed restriction: -150 kcal kg-1 of metabolizable energy), with four replicates of one animal each. The experimental diets were isonutritives, except for the metabolizable energy level of the diet fed to the group subjected to energy restriction. There were no effects on the growth performance and carcass characteristics. Ractopamine and organic chromium (picolinate and yeast) supplementation increased the concentration of total polyunsaturated fatty acid. The proportion of α-linolenic fatty acids were higher when the diets were supplemented with ractopamine or chromium yeast. The energy restriction increased the n-6:n-3 ratio and reduced α-linolenic acid concentration. Therefore, ractopamine, chromium picolinate, chromium yeast supplementation, and energetic feed restriction did not affect the growth performance or carcass characteristics but altered the lipid profile of subcutaneous fat in finishing gilts. Ractopamine and organic chromium supplementation increased PUFA in the fat of finishing female pigs.

Camelina Meal and Chromium Picolinate Effects on Broiler Thigh Meat Nutritional Properties

Abstract The aim of this study was to evaluate the combined effects of trivalent chromium and camelina meal on proximate composition, mineral content and fatty acids profile of broiler chicken thigh meat. An experiment with 2 x 3 factorial arrangement was performed on 240 Ross 308 broiler chicken aged 14 days. Six dietary treatments were elaborated as follows: 0 and 3% inclusion rate of Camelina meal and 0, 200 and 400 μg/kg chromium picolinate (CrPic). Supplementation of broiler diets with 3% Camelina meal led to significantly (P&lt;0.05) increased crude fat concentrations in thigh samples compared to control group or with single chromium supplemented groups. In thigh samples, Zn and Fe concentrations increased under CrPic influence and fatty acids profile was influenced by Camelina meal presence in the diets. In Camelina meal supplemented groups, were registered significantly increased omega 3 fatty acids concentrations compared to control group or single chromium supplemented groups. The results of the present study found that Camelina meal and chromium picolinate supplements in broilers diets improved the nutritional properties of thigh meat, especially essential minerals content and fatty acids profile.

Effects of chromium supplementation on oxidative stress biomarkers.

Aim: This systematic review and meta-analysis aimed to evaluate the effects of chromium supplementation on oxidative stress biomarkers such as superoxide dismutase (SOD), glutathione (GSH), glutathione peroxidase (GPX), malondialdehyde (MDA), total antioxidant status (TAS), thiobarbituric acid reactive substances (TBARS), catalase (CAT), nitric oxide (NO), total antioxidant capacity (TAC) and protein carbonyl. Methods: Relevant studies, published from inception until July 2019, were searched through PubMed/Medline, Scopus, ISI Web of Science, Embase, and Google Scholar. All randomized clinical trials investigating the effect of chromium supplementation on oxidative stress were included. Results: Out of 252 citations, 10 trials that enrolled 595 subjects were included. Chromium supplementation resulted in a significant increase in GSH (WMD: 64.79 mg/dl, 95% CI: 22.43 to 107.15; P=0.003) but no significant change in MDA, TAS, TBARS levels, SOD, CAT levels and GPX. Chromium picolinate supplementation resulted in a significant increase in TAC while failing to have a significant effect on NO. Moreover, both chromium picolinate and chromium dinicocysteinate supplementation reduced protein carbonyl levels. Conclusion: Overall, this meta-analysis demonstrated that chromium supplementation increased GSH without any significant changes in the mean of GPX, MDA, TAS, TBARS, CAT and SOD.

Effects of dietary chromium picolinate supplementation on broiler growth performance: A meta-analysis.

ObjectiveA meta-analysis was conducted to assess the effects of dietary chromium picolinate (CrPic) supplementation on broiler growth performance and to determine whether such effects are regulated by broiler strains, sex, environmental stress, or contextual factors including study area and years.MethodsEligible studies were identified by searching the Web of Science, Springer, Elsevier, ScienceDirect, Taylor & Francis Online databases. Weighted average differences with corresponding 95% confidence intervals were computed with a random-effects model. We performed subgroup analysis stratified by study area, published years, broiler strains and sex, and environmental stress. Publication bias was assessed with Egger’s test method. A total of 15 studies eligible for inclusion.ResultsThe results indicated that CrPic supplementation significantly improved broiler growth performance and subgroup analysis confirmed this conclusion. We also found that Ross 308 or male broilers might be more sensitive to CrPic supplementation and showed better growth performance. A model was used to obtain the amount of chromium addition under the optimal growth performance, which suggested that the maximum value of average daily gain (ADG) was reached when chromium addition was 1810 μg/kg. The results of the sensitivity analysis showed low sensitivity and high stability of the meta-analysis.ConclusionsCrPic supplementation had a positive effect on the growth performance of broilers, and this meta-analysis provides a more accurate value of chromium addition, which may be beneficial for the practice of the broiler industry.

Improvement in the growth status and carbohydrate utilization of Labeo rohita (Hamilton, 1822) fingerlings with dietary supplementation of chromium picolinate.

A 60-day feeding experiment was conducted to evaluate the effects of dietary chromium (Cr) on carbohydrate utilization and growth performance of Labeo rohita fingerlings. Fishes were fed with four high carbohydrate (53%), isonitrogenous (crude protein 35%), and isocaloric (415 Kcal, 100 gm-1) experimental diets containing different levels of dietary chromium picolinate (Cr-Pic) viz.0, 400, 800, and 1200 μg kg-1 diet. Weight gain (WG%), specific growth rate (SGR), feed efficiency ratio (FER), and protein efficiency ratio (PER) were significantly increased at 800 μg kg-1 diet chromium supplementation (P < 0.05). Cr-Pic supplementation (800 μg kg-1) also significantly (P < 0.05) enhanced the protein: DNA ratio in muscle, while DNA: RNA and DNA: tissue ratios were significantly (P < 0.05) decreased indicating higher growth. Significantly higher amylase, protease, and lipase activities were recorded in 800 μg Cr-Pic kg-1 diet fed fishes (P < 0.05), while any of the experimental groups showing no significant (P > 0.05) change in hexokinase activity, indicating normal glycolysis in all. Furthermore, significant (P < 0.05) decrease of glucose-6-phospatase activity in 800 μg Cr-Pic kg-1 diet fed group, showcasing an evidence for protein-sparing action with Cr-Pic supplementation. Significantly (P < 0.05) higher serum insulin and liver glycogen in 800 μg Cr-Pic kg-1 diet fed fishes denote an improvement in carbohydrate metabolism. However, significantly (P < 0.05) higher ATPase and SOD activities were also observed when chromium supplementation was more than 800 μg kg-1 diet, indicating stress at higher level. The present study indicates that growth and carbohydrate utilization can significantly (P < 0.05) be improved by feeding the L. rohita fingerlings with Cr-Pic (800 μg kg-1 diet) supplemented diet in laboratory condition.

Chromium picolinate supplementation improves growth and resistance ability in the sea cucumber Apostichopus japonicus .

Abstract Poor performances in growth and resistance ability greatly hamper the aquaculture of the sea cucumber Apostichopus japonicus . Here, sea cucumbers were fed artificial diets with four concentrations of dietary Cr-Pic supplementation (0, 0.3, 0.6, 0.9 mg/kg) for 56 days. The growth, digestive enzyme activities (LPS, AMS and pepsin), expression of growth-related genes ( MAPK-7 , FGFR-1 and c-myc ) and resistance ability (immune responses and antioxidant system) were subsequently assessed. The present study found that the SGR and BWG in 0.6 mg/kg group were significantly higher than those in control group. Significantly better activities of LPS and AMS and higher expressions of genes MAPK-7 and c-myc were consistently detected in 0.6 mg/kg group than those in control group, suggesting that dietary Cr-Pic supplementation greatly improves the food utilization and genes expression and consequently promotes the growth performances in sea cucumbers. Further, the activities of immune enzymes (AKP, ACP and LZM) and antioxidant enzymes (SOD and T-AOC) in 0.6 mg/kg group were significantly higher than those in control group, indicating that dietary Cr-Pic supplementation significantly enhances the resistance ability of sea cucumbers. The present study provides valuable information for improving the production efficiency of sea cucumbers A. japonicus .

A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial

BackgroundEvaluating the impact of chromium picolinate supplementation on glycemic status, lipid profile, inflammatory markers and fetuin-A in patients with non-alcoholic fatty liver disease (NAFLD). MethodsIn present research, participants (N = 46) were randomized to (400 mcg/day, n = 23) chromium picolinate and placebo (n = 23) for 3 months. ResultsGlucose indices, and lipid profiles, inflammatory biomarker and fetuin-A were measured before and after the intervention. Chromium reduced triglyceride (TG), atherogenic index of plasma (AIP), very-low-density lipoprotein (VLDL), insulin, homeostatic model assessment for insulin resistance (HOMA-IR), high-sensitivity C-reactive protein (hs-CRP), interleukin (IL) -6, tumor necrosis factor-alpha (TNF-α) and fetuin-A significantly compared to placebo group (p < 0.05). Furthermore, chromium significantly increased the quantitative insulin sensitivity check index (QUICKI). There were no significant differences in total cholesterol (TC), high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), fasting blood sugar (FBS), Hemoglobin A1c (HbA1C), interleukin (IL)-17 between the two groups (p < 0.05). ConclusionChromium picolinate significantly decreased TG, insulin, HOMA-IR, fetuin-A, the number of inflammatory factors, and increased QUICKI without changing FBS, HbA1C, TC, LDL, HDL, IL-17 levels and liver steatosis intensity in patients with NAFLD. Further studies by examining the effect of different doses of chromium and mechanisms of cellular action, would help further clarify the subject.

Protective Effects of Chromium Picolinate Against Diabetic-Induced Renal Dysfunction and Renal Fibrosis in Streptozotocin-Induced Diabetic Rats.

Diabetic nephropathy (DN) is one of the most important complications of diabetes, and the leading cause of end-stage renal disease (ESRD). While Chromium picolinate (CrPic) supplementation has been found to be effective in treating diabetes, its effects on diabetic-induced nephropathy have not been studied. Therefore, in this study, CrPic (1 mg kg−1 d−1) was administered to a DN rat model by oral gavage for eight weeks to investigate its effects. The results show that CrPic supplementation caused a decrease in levels of blood glucose, serum insulin, blood urea nitrogen (BUN), serum creatinine, and urinary albumin in DN rats. It also reversed renal pathological changes, including renal glomerular sclerosis and interstitial fibrosis. In addition, the oxidative defense system in the kidneys of DN rats was found to be improved; the biological activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPX) increased; and the content of malondialdehyde (MDA) lowered. Immunohistochemical results reveal that the expression levels of renal transforming growth factor-β1 (TGF-β1), Smad 2, and Smad 3 decreased significantly in the kidneys of rats in the CrPic-treated group. CrPic administration was thus found to ameliorate diabetic nephropathy in SD rats via an antioxidative stress mechanism, as well the ability to inhibit TGF-β1/Smad2/3 expression. This study suggests that CrPic could be a potential renal-protective nutrient against diabetic nephropathy.

Effects of Chromium Picolinate Supplementation on Cardiometabolic Biomarkers in Patients with Type 2 Diabetes Mellitus: a Randomized Clinical Trial.

Type 2 diabetes mellitus (T2DM) is a serious public health problem accompanies with several complications. This study was conducted to evaluate the effects of chromium picolinate (CrPic) supplementation on the glycemic status and lipid profile in patients with T2DM. The patients with T2DM (n = 52) were randomly allocated into 2 groups. One group received 400 µg CrPic per day and the other group took placebo; the intervention duration was 8 weeks. Anthropometric indices and metabolic factors were measured at the beginning, and at end of the study. The patients were recommended not to change their normal diet, life style and medication. No significant changes were observed for weight, body mass index, and fasting blood glucose (FBG) in both groups; while intra-groups changes in homeostatic model assessment for insulin resistance (HOMA-IR) value was significant (p < 0.05). Results of analysis of covariance showed that there were significance differences between groups in total cholesterol, low density lipoprotein cholesterol and HOMA-IR at the end of the intervention adjusting for baseline levels (p = 0.035, 0.030 and < 0.001, respectively). In this study, oral supplementation with 400 µg CrPic for eight weeks did not alter FBG concentration as well as anthropometric parameters in individuals with T2DM. However, the modest beneficial effects of chromium supplementation on insulin resistance as indicated by HOMA-IR and lipid profile were found.

Effect of Chromium Picolinate Supplementation Combined With Resistance Training on Liver Enzymes Levels and Insulin Resistance in Patients With Type 2 Diabetes

Effect of Chromium Picolinate Supplementation Combined With Resistance Training on Liver Enzymes Levels and Insulin Resistance in Patients With Type 2 Diabetes

Long-term chromium picolinate supplementation improves colostrum profile of Santa Ines ewe

Chromium (Cr) is a micromineral that is involved in the metabolism of carbohydrates, lipids, ammonia, and nucleic acids; thus, its supplementation can influence the nutritional status of ruminants, and consequently, colostrum profile, since this secretion depends on products secreted by the mammary gland and elements of the maternal bloodstream. The present study investigated the influence of supplementation with Cr bound to organic molecule on the nutritional, immune, and antioxidant quality of ewe colostrum. Thirty-two multiparous Santa Ines ewes (55.3 ± 8.00kg body weight) were randomly assigned into four groups: T1 (0.0mg of chromium picolinate (CrPic) supplementation per ewe, n = 8), T2 (0.15mg of CrPic per ewe, n = 9), T3 (0.30mg of CrPic per ewe, n = 7), and T4 (0.45mg of CrPic per ewe, n = 8). Supplementation was supplied during the breeding season, pregnancy, and lactation. Shortly after calving, the first milking colostrum was collected to determine its chemical composition, activity of lysozyme, lactoperoxidase, ceruloplasmin, catalase, glutathione peroxidase, and oxygen radical absorbance capacity. The results show that lactoperoxidase activity decreased with CrPic supplementation (P < 0.01), revealing that this micromineral reduces an important component of defense mechanism in the body. Therefore, the results of this work show that supplementation with chromium picolinate influences colostrum quality.

The therapeutic effectiveness of sitagliptin with niacin and chromium picolinate on glycosylated hemoglobin in type 2 diabetes mellitus patients

Purpose: The purpose of this study was to evaluate the effectiveness of niacin (B3) on glycosylated hemoglobin (HbA1c), alone and as adjunct therapy, with chromium picolinate (CrPlt) and sitagliptin. In the present study, we have evaluated the effects of niacin and chromium picolinate supplementation with sitagliptin in Type 2 diabetes mellitus (T2DM) patients.&#x0D; Methods: A randomized controlled trial was conducted on 600 patients suffering from T2DM from four different hospitals in Lahore, Punjab, Pakistan; patients were divided into three groups (n=200 per group). Group A was given sitagliptin (100 mg), Group B received niacin (14 mg/d) along with sitagliptin, and Group C received chromium picolinate (200 mcg/d) and niacin (14 mg/d) along with sitagliptin, for a duration of 6 months. Analysis of variance (ANOVA) was used to compare the efficacy of all treatment groups, and statistical significance was set at p≤0.05.&#x0D; Results: The data indicated that all defined therapies have a significant influence with respect to fasting blood sugar (FBS) (p&lt;0.0001), random blood sugar (RBS) (p&lt;0.0001) and glycosylated hemoglobin (p&lt;0.0001).&#x0D; Conclusion: Our study demonstrated that low doses of niacin and chromium picolinate supplementation with sitagliptin helps in maintaining glycemic control in patients with T2DM, and provides the best treatment option among those considered.